Acrivon Therapeutics, Inc.·4

Nov 18, 4:32 PM ET

Peterson Katharine 4

4 · Acrivon Therapeutics, Inc. · Filed Nov 18, 2024

Insider Transaction Report

Form 4
Period: 2024-11-14
Peterson Katharine
Chief Accounting Officer
Transactions
  • Tax Payment

    Common Stock

    2024-11-14$7.92/sh99$7844,535 total
Footnotes (1)
  • [F1]Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.

Documents

1 file
  • 4
    form4.xmlPrimary